Transchem

Transchem PEG

The PEG Ratio (Price/Earnings-to-Growth) of Transchem (500422.BO) as of Oct 20, 2026 is 0.88. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.72 — a change of 21.67% (higher).

PEG

0.88

YoY

21.67%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Transchem is 2026 0.88 . PEG Ratio (Price/Earnings-to-Growth) of Transchem was 2025 0.72 . It decreases by 21.67% higher compared to the previous year.

The Transchem PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2019
12.36 INR
Jan 1, 2020
9.21 INR
Jan 1, 2021
0.16 INR
Jan 1, 2022
1.31 INR
Jan 1, 2023
3.05 INR
Jan 1, 2024
0.90 INR
Jan 1, 2025
0.72 INR
Jan 1, 2026
0.88 INR
The Transchem PEG history
YEARPEGYoY
0.88+21.67%
0.72-19.57%
0.90-70.57%
3.05+131.85%
1.31+742.00%
0.16-98.30%
9.21-25.53%
12.36-84.66%
80.58+152.62%
31.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Transchem Stock analysis

What does Transchem do? Transchem Ltd is a pharmaceutical company based in Thane, India, operating within the Health Care sector. The company has been publicly traded since its IPO on January 27, 1993, with a ticker symbol of 500422.BO and ISIN code INE019B01010. Its headquarters are located in Thane, Maharashtra. Transchem Ltd is engaged in the production and processing of pharmaceutical products, though specific product details are not provided. The company's website is https://www.transchem.net/. While the source description mentions the company's involvement in mushroom production, this appears to be an unverified or incorrect detail, as the company is classified under the Pharmaceuticals industry. The source also states that the company temporarily invests funds in short-term treasury operations while seeking new business opportunities, but this information should be treated with caution as it is not confirmed by official company sources. The company's primary focus remains on pharmaceutical manufacturing and processing within the Indian market. No additional details about its founding year, key personnel, acquisitions, or financial figures are provided in the available information. Transchem Ltd operates as a publicly listed entity on the Bombay Stock Exchange, though specific market capitalization or trading volume data is not included in the given facts. The company's activities are centered around pharmaceutical production, with no indication of other significant business lines beyond those related to the Health Care sector. Transchem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Transchem stock

PEG Ratio (Price/Earnings-to-Growth) of Transchem is 0.88 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Transchem changed from 0.72 to 0.88, representing a 21.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Transchem since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Transchem with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Transchem

All Key Metrics — Transchem